ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Indo Borax & Chemicals Ltd reported revenue from operations of ₹58.9 Cr (+1.9% YoY) and net profit of ₹4.7 Cr (-71.2% YoY) for Q2 FY27.
Indo Borax pledged 14% of Kronox Lab Sciences shares as security for a ₹225 crore term loan. Kronox remains its subsidiary.
Indo Borax & Chemicals will hold a board meeting on 6 November 2026 to approve unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026. Trading window remains closed until 48 hours after results.
Indo Borax & Chemicals amended its Share Purchase Agreement dated August 20, 2026, by removing lock-in restrictions and the right of first refusal. This amendment clarifies promoter status.
Indo Borax & Chemicals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Indo Borax created a pledge over 14% of subsidiary Kronox's shares to secure a ₹225 crore term loan. The pledge does not alter the company's control of the subsidiary.
Indo Borax & Chemicals Ltd issued a notice of postal ballot to seek shareholder approval for creating security on borrowings up to Rs. 400 Crore. Voting will occur via remote e-voting.
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited for ₹246.12 Crore.
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited. The transaction involved purchasing 2,38,44,000 equity shares via a share purchase agreement.
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
Indo Borax & Chemicals reported postal ballot results where shareholders approved borrowing limits up to Rs 400 Crore. One special resolution passed with 98.05% in favour.
Indo Borax reported robust Q1 FY27 results with 31% revenue growth and 59% PAT growth. Management announced a major acquisition of 64.26% stake in Kronox Lab Sciences to diversify into high-purity specialty chemicals.
Indo Borax reported strong Q1FY27 consolidated performance with Revenue up 31% and PAT up 59% YoY. Strategy focuses on high-margin DOT expansion and the acquisition of Kronox Lab Sciences.
Indo Borax & Chemicals Ltd received a credit rating update from India Ratings, placing its bank loan facilities on 'Rating Watch with Negative Implications'.
Indo Borax & Chemicals Ltd. is relocating its corporate office to a new premises in Andheri (East), Mumbai, effective September 15, 2026.
Indo Borax & Chemicals Limited has announced the acquisition of Kronox Lab Sciences Limited for Rs. 103.22 Crore. The cash deal aims to diversify the company's chemical portfolio.
Indo Borax & Chemicals approved the acquisition of a 64.26% stake in Kronox Lab Sciences for ₹246.12 Crore. The transaction triggers a mandatory open offer for another 25.79%.